Citation Information :
Jagannath S, Mayilvaganan S. Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-risk Papillary Thyroid Carcinoma with Lymph Node Metastasis. 2023; 18 (1):38-38.
Xu S, Huang H, Huang Y, et al. Comparison of lobectomy vs total thyroidectomy for intermediate-risk papillary thyroid carcinoma with lymph node metastasis. JAMA Surg 2023;158(1):73–79. DOI: 10.1001/jamasurg.2022.5781.
Mulder MB, Duh Q. Is lobectomy as effective as total thyroidectomy in treating patients with intermediate-risk papillary thyroid carcinoma with lateral lymph node metastasis? JAMA Surg 2023;158(1):80. DOI: 10.1001/jamasurg.2022.5790.
Powers AE, Marcadis AR, Lee M, et al. Changes in Trends in Thyroid Cancer Incidence in the United States, 1992 to 2016. JAMA 2019;322(24):2440–2441. DOI: 10.1001/jama.2019.18528.
Ito Y, Miyauchi A, Kihara M, et al. Overall survival of papillary thyroid carcinoma patients: A single-institution long-term follow-up of 5897 patients. World J Surg 2018;42(3):615–622. DOI: 10.1007/s00268-018-4479-z.
Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016;26(1):1–133. DOI: 10.1089/thy.2015.0020.